Table of Contents
Overview
New York, NY – May 29, 2025 – Global Surgical Snare Market size is expected to be worth around US$ 2.71 billion by 2034 from US$ 1.73 billion in 2024, growing at a CAGR of 4.6% during the forecast period 2025 to 2034.
The global surgical snare market is witnessing steady growth, driven by the increasing adoption of minimally invasive surgical techniques and a rising burden of gastrointestinal and respiratory diseases. Surgical snares are loop-shaped instruments used for excision of polyps, foreign bodies, or abnormal tissues during endoscopic procedures. These devices play a critical role in procedures involving the colon, stomach, esophagus, and bronchial pathways.
A significant rise in colorectal cancer screening, fueled by global awareness campaigns and aging populations, has led to greater demand for endoscopic polypectomies, directly supporting market expansion. Technological advancements in snare design such as rotatable, multi-functional, and cold snares have further improved procedural safety, efficiency, and precision.
Hospitals, ambulatory surgical centers, and specialty clinics are the primary end-users, benefiting from streamlined workflow and reduced recovery times offered by surgical snares. The integration of advanced endoscopy systems and increased healthcare investments in emerging markets are also expected to accelerate adoption rates.
North America and Europe currently dominate the market due to their well-established healthcare infrastructure, while Asia-Pacific is projected to exhibit the fastest growth, driven by increasing healthcare access and rising incidence of gastrointestinal disorders. With a growing focus on non-invasive interventions and early-stage disease management, the surgical snare market is well-positioned for continued expansion over the coming years.
Key Takeaways
- In 2024, the Surgical Snare market generated revenue of USD 73 million and is projected to reach USD 2.71 billion by 2034, growing at a CAGR of 4.6% over the forecast period.
- Based on Type, the Single-use segment led the market in 2024 with a dominant share of 58.3%, driven by its advantages in sterility, convenience, and reduced risk of cross-contamination.
- In terms of Application, the GI Endoscope segment accounted for the largest share at 30.2%, supported by the increasing number of endoscopic procedures, especially for polyp removal and gastrointestinal diagnostics.
- Regarding End-Use, Hospitals and Clinics emerged as the leading segment, contributing 65.0% of the total market revenue. This dominance reflects the widespread use of surgical snares in institutional settings equipped with advanced endoscopy infrastructure.
- Regionally, North America maintained its leading position in the global surgical snare market, capturing a 38.7% share in 2024. The region’s leadership is supported by a well-developed healthcare system, high procedural volumes, and early adoption of minimally invasive technologies.
Segmentation Analysis
- Usability Analysis: In 2024, the single-use snare segment led the market with a 58.3% share, driven by heightened infection control protocols and procedural safety concerns. These snares are discarded after one-time use, eliminating the risk of cross-contamination. Their convenience no need for reprocessing or sterilization makes them ideal for high-volume environments like hospitals and ambulatory surgical centers. The growing preference for sterile, maintenance-free instruments continues to support the dominance of single-use snares in clinical practice.
- Application Analysis: The GI endoscope segment held the largest application share in 2024 at 30.2%, owing to the high frequency of gastrointestinal procedures. Surgical snares in this segment are commonly used for polyp removal and biopsy during colonoscopies and upper GI endoscopies. Rising awareness about gastrointestinal health and preventive screening for cancer is increasing procedural volumes. According to the National Endoscopic Database, over 20 million GI endoscopies are performed annually in the U.S., reinforcing this segment’s strong market position.
- End Use Analysis: Hospitals and clinics dominated the surgical snare market in 2024, accounting for 65.0% of the total share. These facilities manage a higher volume of complex surgeries across specialties such as gastroenterology, urology, and gynecology. Their access to advanced surgical tools and infrastructure boosts the use of snares. Ambulatory surgical centers (ASCs), however, are growing rapidly, driven by the shift toward outpatient care and minimally invasive procedures, which is expanding snare usage in alternative care settings.
Market Segments
By Usability
- Single use
- Reusable
- Kallikrein Inhibitors
- Others
By Application
- GI Endoscope
- Laparoscopy
- Urology Endoscopy
- Gynecology Endoscopy
- Arthroscopy
- Bronchoscopy
- Mediastinoscopy
- Laryngoscopy
- Others
By End Use
- Hospitals and Clinics
- Ambulatory Surgical Centers
Regional Analysis
In 2024, North America held a leading position in the global surgical snare market, capturing 38.7% of the total market share. This dominance is attributed to the region’s advanced healthcare infrastructure, high healthcare spending, and growing preference for minimally invasive surgical procedures. The United States and Canada are the primary contributors, with hospitals, outpatient clinics, and ambulatory surgical centers (ASCs) conducting a large volume of procedures involving snares, such as endoscopy, laparoscopy, and urology surgeries.
The increasing prevalence of chronic conditions including gastrointestinal disorders, cancers, and urological diseases combined with a rising elderly population, continues to boost the demand for surgical snares. Technological innovations in snare devices, such as electrosurgical and robotic-assisted systems, are further enhancing procedural outcomes and efficiency. Moreover, favorable reimbursement frameworks and the broader adoption of minimally invasive surgical techniques are expected to sustain and accelerate market growth across the North American region.
Emerging Trends
- Shift to Single-Use Devices: The adoption of disposable snares has increased to reduce infection risks and simplify sterilization protocols. Single-use polypectomy snares are now classified as Class II devices by the FDA, reflecting their growing acceptance in clinical practice.
- Broadened Clinical Indications: Surgical snares are being utilized beyond gastrointestinal polypectomy. They are increasingly applied for foreign-body retrieval in cardiovascular interventions, with devices such as the Radius Snare approved for vascular object manipulation.
- Emphasis on Electrosurgical Integration: Electrosurgical snares combining mechanical cutting with thermal coagulation have become a standard for tissue resection. Flexible snares (product code FDI) cleared by the FDA demonstrate widespread reliance on this dual-mode technology.
- Enhanced Safety Surveillance: Regulatory monitoring has intensified, exemplified by FDA recalls (e.g., Captivator Polypectomy Snare) to address potential hemorrhage or perforation risks. This vigilance underscores ongoing efforts to maintain device safety in widespread use.
Use Cases
- Colorectal Polypectomy: Electrosurgical snares are employed in the removal of colonic polyps during colonoscopy. Approximately 14.2 million colonoscopies were performed in the U.S. in 2002, underscoring the high volume of snare-assisted resections.
- Early Barrett’s Esophagus Resection: Simple snare-based endoscopic mucosal resection has been shown feasible and effective for removing Barrett’s epithelium with early malignancy in clinical trials, supporting its use in gastrointestinal oncology.
- Foreign-Body Retrieval in Cardiology: Vascular snares are utilized to retrieve or reposition intravascular objects (e.g., coils, guidewires). The FDA-cleared Radius Snare facilitates minimally invasive retrieval procedures within the cardiovascular system.
- Gynecologic Polyp Removal: Hysteroscopic snares (e.g., KSEA HF-Snare) are indicated for uterine polyp and tumor resection. They have been safely used under qualified surgical practice for gynecologic pathology removal.
Conclusion
The global surgical snare market is poised for sustained growth, driven by the rising demand for minimally invasive procedures, increasing gastrointestinal disease prevalence, and technological innovations in snare design. Single-use devices, advanced electrosurgical tools, and expanding clinical applications are enhancing safety, efficiency, and procedural outcomes.
With hospitals and clinics leading adoption and ambulatory centers gaining traction, market penetration continues to deepen. North America remains the dominant region, supported by robust infrastructure and reimbursement systems. As regulatory oversight strengthens and clinical indications broaden, the surgical snare market is expected to remain a vital component of modern surgical and diagnostic practice globally.
Discuss your needs with our analyst
Please share your requirements with more details so our analyst can check if they can solve your problem(s)
